Clinical Trial Update: A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study to assess the effect of GSK1605786 on hepatic cytochrome P450 enzymes and BCRP and OATP1B1 transport in healthy adults; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• GSK1605786

Snippet

Sponsor: GlaxoSmithKline | Conditions: Crohn's Disease | Phase 1 | Status: COMPLETED